mortality/aging
• numbers of mutant offspring identified at weaning (3.7%) are significantly lower than expected Mendelian numbers (25%)
• expected numbers of double mutant offspring are present embryonically and at birth, but many die by P5
|
neoplasm
• at 6-7 months of age, pancreases are indistinguishable from controls; at 16-18 months of age, microcystic adenomas (MCA) are identified; extensive vasculature network is observed in MCA, similar to what is seen in human VHL patients
|
endocrine/exocrine glands
• at 16-18 months of age, significant loss of exocrine pancreas and replacement with fat deposition is observed
|
• at 16-18 months of age, some islets appear small and abnormally shaped without many exocrine acinar cells surrounding them
|
• at 6-7 months of age, pancreases are indistinguishable from controls; at 16-18 months of age, microcystic adenomas (MCA) are identified; extensive vasculature network is observed in MCA, similar to what is seen in human VHL patients
|
• at 6-7 months of age, pancreases are indistinguishable from controls; at 16-18 months of age, cysts are identified
|
digestive/alimentary system
• at 16-18 months of age, significant loss of exocrine pancreas and replacement with fat deposition is observed
|
growth/size/body
• at 6-7 months of age, pancreases are indistinguishable from controls; at 16-18 months of age, cysts are identified
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
von Hippel-Lindau disease | DOID:14175 |
OMIM:193300 |
J:148174 |